The US Patent and Trademark Office is holding two hearings — one this week and other in March — to gather information on "independent second opinion genetic diagnostic testing" on genes that are already patented or exclusively licensed by other companies, reports Patent Docs' Donald Zuhn. USPTO is planning to gather the information it receives from the hearings and make a report to Congress. The panel will also see a video from Representative Debbie Wasserman Schultz (D-Fla.), who introduced an amendment to the Leahy-Smith America Invents Act for patent reform "that would have exempted from infringement a 'genetic diagnostic tester's performance of a confirming generic diagnostic test activity' that would otherwise constitute infringement" under the act, Zuhn says. The Leahy-Smith Act was passed in 2011, but without Wasserman Schultz's amendment, he adds.
Patents, Patents Everywhere
Feb 17, 2012